Changes in dynamic mitral valve geometry during percutaneous edge–edge mitral valve repair with the MitraClip system
The aim of this study was to quantify the acute dynamic changes of mitral valve (MV) geometry throughout the cardiac cycle—during percutaneous MV repair with the MitraClip system by 3-dimensional transesophageal echocardiography (3D TEE).
The MV was imaged throughout the cardiac cycle (CC) before and after the MitraClip procedure using 3D TEE in 28 patients (mean age, 77 ± 8 years) with functional mitral regurgitation (FMR). Dynamic changes in the MV annulus geometry and anatomical MV orifice area (AMVOA) were quantified using a novel semi-automated software.
Percutaneous MV repair decreased anterior–posterior diameter by up to 9% (at 50% of CC; from 34.5 to 31.9 mm; p < 0.001) throughout the CC and increased the diastolic lateral–medial diameter by up to 7% (at 60% of the CC; from 39.7 to 42.3 mm; p < 0.001), whereas the annular circumference and area were not significantly affected. Annulus sphericity index was reduced up to 13% (at 50% of the CC; from 0.89 to 0.78, p < 0.001). The AMVOA also decreased during systole, the maximum decrease being from 0.6 to 0.2 mm2 (at 0% of CC; p = 0.007), and during diastole the maximum decrease being from 4.6 to 1.6 cm2 (at 50% of CC; p < 0.001).
Percutaneous MV repair reduces the MR by an improved coaptation of MV leaflets joint with a simultaneous indirect reduction of anterior–posterior diameter. Further, the MitraClip procedure leads to a reduction of AMVOA of more than 60% during diastole.
KeywordsMitral valve geometry MitraClip Mitral regurgitation 3D echocardiography
Compliance with ethical standards
Conflict of interest
Drs Noack and Vannan have received a speaker honorarium from Siemens Healthcare. Philipp Kiefer, Linda Mallon, Philipp Lurz, Carmine Bevilacqua, Joergen Banusch, Fabian Emrich, David M Holzhey, Holger Thiele, Friedrich-Wilhelm Mohr, Michael Andrew Borger, Joerg Ender and Joerg Seeburger declare that they have no conflict of interest.
Research involving human participants
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions.
Informed consent was obtained from all patients for being included in the study.
Video 1 Video shows the 3D TEE-based mitral valve model after the implantation of 2 clips in the leaflet segments of A2 and P2. Further, automatically model-based quantification of annular height to commissural width ration of the mitral valve is demonstrated (MP4 10774 kb)
- 2.Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62(12):1052–61.CrossRefGoogle Scholar
- 6.Schueler R, Momcilovic D, Weber M, et al. Acute changes of mitral valve geometry during interventional edge-to-edge repair with the MitraClip system are associated with midterm outcomes in patients with functional valve disease: preliminary results from a prospective single-center study. Circ Cardiovasc Interv. 2014;7(3):390–9.CrossRefGoogle Scholar
- 13.Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.CrossRefGoogle Scholar
- 14.Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardio-thorac Surg. 2012;42(4):S1–44.CrossRefGoogle Scholar